1615876

Sorafenib Tosylate

United States Pharmacopeia (USP) Reference Standard

• 別名: 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide, 4-methylbenzenesulfonic acid
• 実験式（ヒル表記法）: C₂₁H₁₆ClF₃N₄O₃·C₇H₈SO₃
• CAS番号: 475207-59-1
• 分子量: 637.03
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• APIファミリー: sorafenib
• メーカー／製品名: USP
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: −20°C
• InChI: 1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)
• InChI Key: IVDHYUQIDRJSTI-UHFFFAOYSA-N

詳細

詳細

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

アプリケーション

Sorafenib Tosylate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Regorafenib
• Sorafenib Tablets
• Sorafenib Tosylate

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08,GHS09
• シグナルワード: Danger
• 危険有害性情報: H360FD,H362,H372,H410
• 注意書き: P202 - P260 - P263 - P264 - P273 - P308 + P313
• 危険有害性の分類: Aquatic Acute 1 - Aquatic Chronic 1 - Lact. - Repr. 1B - STOT RE 1
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable